Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Projects selected for MSD-backed digital accelerator

Disease-specific mobile apps among those winning support from Velocity Health

Digital pharmaA simple video-based remote care service, and disease-specific mobile apps and wearable technology were among the recipients of an MSD, UK-backed digital healthcare accelerator programme.

Velocity Health, run by both MSD UK and Wayra, UK, will hand each of the winners from its demo day event up to £68k in investments. 

Mike Nally, managing director of MSD UK, said: “What we're seeing is the future of healthcare delivery in the UK - innovative products and services that will not only test the capabilities of what's possible and put the patient at the heart of everything we do, but hopefully help society to become as good at 'recognising and preventing' disease as we are at 'diagnosing and treating'.

“As a healthcare company with a proud legacy of investing in innovation and R&D, we are delighted to be able to help harness and nurture this amazing talent.”

In additional to Aparito, which combines disease specific mobile apps and wearable technology, and remote care system Speakset, two other initiatives were rewarded by the programme. 

They were cloud-based application Tickerfit, which enables healthcare professionals to provide personalised lifestyle interventions, and Mom incubator which is an inexpensive, electronically-controlled, inflatable incubator designed to decrease the premature child deaths within refugee camps.

From February 2016, the startups will begin a 10-month accelerator programme with support from a network of mentors, coaches and investors to enable them to scale up.

9th December 2015

From: Healthcare

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...